Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Abnormal Blood Results Predict Poor Prognosis in Autoimmune Disease

By LabMedica International staff writers
Posted on 01 Jul 2010
Patients suffering from a disorder of the connective tissue who have blood based deficiencies will steadily deteriorate.

In Primary Sjogren's Syndrome (pSS) patients, concurrent anemia, lymphocytopenia, or hypocomplementemia are strong indicators that the outcome will be poor. More...
The patients may progress to other manifestations such as lymphoma.

In a study carried out at the Vall D'Hebron University Hospital (Barcelona, Spain), 244 patients with pSS were followed for 20 years. Those with the abnormal hematological manifestations showed a progression towards such diseases as non-Hodgkin's lymphoma and other malignancies (including lung, colon, breast, and gynecologic neoplasms).

An excess mortality due to lymphoproliferative malignancies was found in patients with pSS. The existence of pulmonary (lung fibrosis, brochiectasis) and hepatic (biliary cirrhosis, autoimmune hepatitis) involvement were also shown to be independent risk factors related to mortality.

Primary Sjogren's Syndrome is often characterized by changes in exocrine function. However, this study has determined the profile of some of the non-exocrine signs of the disease, including the pulmonary, hematologic, and hepatic manifestations. The results of the study were presented recently at the Annual Congress of the European League Against Rheumatism in Rome, Italy (EULAR 2010).

Primary Sjogren's Syndrome is an autoimmune disease in which immune cells attack and destroy moisture-producing glands. In patients with pSS, the immune system targets moisture-producing glands and causes dryness in the mouth and eyes. Other parts of the body can be affected as well, resulting in a wide range of possible symptoms.

Sjögren's syndrome affects one to four million people in the United States, most of whom are more than 40 years old at the time of diagnosis, and women are nine times more likely to have the disease than men.

Related Links:

Vall D'Hebron University Hospital




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.